pubmed-article:12466281 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:12466281 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
pubmed-article:12466281 | lifeskim:mentions | umls-concept:C0105770 | lld:lifeskim |
pubmed-article:12466281 | lifeskim:mentions | umls-concept:C1333547 | lld:lifeskim |
pubmed-article:12466281 | lifeskim:mentions | umls-concept:C0033684 | lld:lifeskim |
pubmed-article:12466281 | lifeskim:mentions | umls-concept:C1538613 | lld:lifeskim |
pubmed-article:12466281 | lifeskim:mentions | umls-concept:C0449205 | lld:lifeskim |
pubmed-article:12466281 | pubmed:issue | 7 | lld:pubmed |
pubmed-article:12466281 | pubmed:dateCreated | 2003-2-10 | lld:pubmed |
pubmed-article:12466281 | pubmed:abstractText | Beta-catenin is a key mediator of the Wnt pathway, which plays a critical role in embryogenesis and oncogenesis. As a transcriptional activator, beta-catenin binds the transcription factors, T-cell factor and lymphoid enhancer factor, and regulates gene expression in response to Wnt signaling. Abnormal activation of beta-catenin has been linked to various types of cancer. In a yeast two-hybrid screen, we identified the four and a half of LIM-only protein 2 (FHL2) as a novel beta-catenin-interacting protein. Here we show specific interaction of FHL2 with beta-catenin, which requires the intact structure of FHL2 and armadillo repeats 1-9 of beta-catenin. FHL2 cooperated with beta-catenin to activate T-cell factor/lymphoid enhancer factor-dependent transcription from a synthetic reporter and the cyclin D1 and interleukin-8 promoters in kidney and colon cell lines. In contrast, coexpression of beta-catenin and FHL2 had no synergistic effect on androgen receptor-mediated transcription, whereas each of these two coactivators independently stimulated AR transcriptional activity. Thus, the ability of FHL2 to stimulate the trans-activating function of beta-catenin might be dependent on the promoter context. The detection of increased FHL2 expression in hepatoblastoma, a liver tumor harboring frequent beta-catenin mutations, suggests that FHL2 might enforce beta-catenin transactivation activity in cancer cells. These findings reveal a new function of the LIM coactivator FHL2 in transcriptional activation of Wnt-responsive genes. | lld:pubmed |
pubmed-article:12466281 | pubmed:language | eng | lld:pubmed |
pubmed-article:12466281 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:12466281 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:12466281 | pubmed:month | Feb | lld:pubmed |
pubmed-article:12466281 | pubmed:issn | 0021-9258 | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:QiY FYF | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:NeuveutChrist... | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:BuendiaMarie-... | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:WuYuanfeiY | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:RenardClaire-... | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:FlajoletMarcM | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:LévyLaurenceL | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:PrigentSylvie... | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:LabaletteChar... | lld:pubmed |
pubmed-article:12466281 | pubmed:author | pubmed-author:PrieurXavierX | lld:pubmed |
pubmed-article:12466281 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:12466281 | pubmed:day | 14 | lld:pubmed |
pubmed-article:12466281 | pubmed:volume | 278 | lld:pubmed |
pubmed-article:12466281 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:12466281 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:12466281 | pubmed:pagination | 5188-94 | lld:pubmed |
pubmed-article:12466281 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:meshHeading | pubmed-meshheading:12466281... | lld:pubmed |
pubmed-article:12466281 | pubmed:year | 2003 | lld:pubmed |
pubmed-article:12466281 | pubmed:articleTitle | Identification of the LIM protein FHL2 as a coactivator of beta-catenin. | lld:pubmed |
pubmed-article:12466281 | pubmed:affiliation | Unité de Recombinaison et Expression Génétique, Institut Pasteur, INSERM U163, 28 rue du Dr. Roux, 75015 Paris, France. ywei@pasteur.fr | lld:pubmed |
pubmed-article:12466281 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:12466281 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
entrez-gene:1499 | entrezgene:pubmed | pubmed-article:12466281 | lld:entrezgene |
entrez-gene:2274 | entrezgene:pubmed | pubmed-article:12466281 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12466281 | lld:entrezgene |
http://linkedlifedata.com/r... | entrezgene:pubmed | pubmed-article:12466281 | lld:entrezgene |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:12466281 | lld:pubmed |